已收盘 09-19 16:00:00 美东时间
+0.130
+0.32%
Calliditas Therapeutics AB (NASDAQ:CALT) said on Monday that Nasdaq Stockholm has decided the company will be delisted from Nasdaq Stockholm. The last day of trading in the share will be on Thursday, ...
09-16 22:45
Calliditas Therapeutics (CALT) has released an update. Calliditas Therapeutics,...
09-04 04:51
Asahi Kasei (JP:3407) has released an update. Asahi Kasei Corporation successfu...
09-03 09:27
Calliditas Therapeutics (CALT) has released an update. Calliditas Therapeutics ...
08-14 04:38
Calliditas Therapeutics (NASDAQ:CALT) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.13) by 26.92 percent. This is a 49.23 percent increase over losses of $(0.33) per
08-13 13:40
Novartis (NYSE:NVS) has received FDA accelerated approval for its drug Fabhalta to be used in the reduction of proteinuria in adults with primary immunoglobulin A nephropathy, or IgAN, at risk of rapi...
08-08 04:57
STOCKHOLM, July 31, 2024 /PRNewswire/ -- During July, the number of shares and ...
07-31 20:23
Calliditas Therapeutics (CALT) has released an update. Calliditas Therapeutics ...
07-27 04:27
Calliditas (NASDAQ:CALT) said its partner STADA has received full EU marketing authorization for the drug Kinpeygo for the treatment of adults with primary immunoglobulin A nephropathy, or IgAN. Kinpe...
07-27 03:52
alliditas Therapeutics AB (NASDAQ:CALT) (STOCKHOLM: CALTX) ("Calliditas") today announced that the Phase 2b TRANSFORM trial met its primary endpoint, showing statistically significant
07-26 14:53